Meyka Pro banner
Market News

Varun Beverages Ltd Stock in Focus as Morgan Stanley Highlights RTD, Alcobev Opportunity

August 26, 2026
01:33 PM
5 min read

Key Points

Morgan Stanley retains an Overweight rating and a ₹557 target for Varun Beverages stock.

VBL is entering the RTD and alcobev market through KIVA Spirits.

Q2 CY2026 revenue rose 20.4% YoY to ₹8,451 crore.

Meyka's AI forecast points to ₹739.33 crore over one year.

Be the first to rate this article

Varun Beverages Ltd stock is back in focus on August 26, 2026, after the company announced plans to enter the ready-to-drink (RTD) alcoholic beverages market through KIVA Spirits. Morgan Stanley retained its Overweight rating and a ₹557 target price, pointing to more than 27% potential upside. The move gives the PepsiCo bottler another growth avenue as investors assess whether its established distribution network can support expansion beyond its traditional soft drink business.

Why Morgan Stanley Sees More Upside in Varun Beverages Stock?

Morgan Stanley retained its Overweight rating on Varun Beverages and kept its ₹557 target price on August 26, 2026. The target suggests meaningful upside from recent trading levels. The brokerage sees VBL’s entry into ready-to-drink (RTD) and alcoholic beverages as a potential new source of growth.

The board has approved KIVA Spirits and Company Limited, a wholly owned subsidiary focused on RTD, alcoholic beverages, and related products, subject to regulatory approvals. Morgan Stanley said the move is in line with management’s earlier comments about the RTD opportunity. It is still waiting for more details on the business plan before estimating the full earnings impact.

The new business could also allow VBL to put its existing distribution network to work across additional beverage categories.

VBL’s RTD and Alcobev Strategy: What Investors Need to Watch

New Alcohol Subsidiary and Ex-Diageo Leadership

Why is Varun Beverages entering the alcohol market? The company has appointed Prathmesh Mishra as CEO and Managing Director of the proposed subsidiary. Mishra is a former Diageo executive with extensive experience in the consumer and alcoholic beverages sector. His background gives VBL specialist experience as it moves into a new category.

The company has not yet provided a full product portfolio, launch schedule, or investment plan. Investors should be careful about assuming significant alcohol revenue before those details become clear.

From Soft Drinks to Ready-to-Drink Alcohol

RTD products could expand VBL’s addressable market. The category also fits with the company’s existing strengths in manufacturing, distribution, and consumer marketing. The proposed business could eventually cover alcoholic RTD products and other related beverages, although regulatory approvals will remain an important factor.

Strong Core Business Gives Varun Beverages Room to Expand

VBL is entering this new market with a strong existing business. In Q2 CY2026, revenue from operations rose 20.4% year on year to ₹8,451.23 crore. Net profit increased 15.1% to ₹1,525.36 crore, while EBITDA rose 17.2% to ₹2,343.04 crore.

Sales volume also increased 19.8% to 466.7 million cases. International volumes grew 38.4%, compared with a 14.4% increase in India. This makes the international business an important contributor to VBL’s overall growth.

Margins were a weaker point during the quarter. EBITDA margin fell to 27.7% from 28.5%, partly due to the lower-margin Twizza business in South Africa. India’s EBITDA margin, in contrast, improved by 38 basis points.

Varun Beverages Stock Price and Key Risks in 2026

Varun Beverages shares fell as much as 3% to ₹425.25 on August 26, following the alcobev announcement. The stock was down about 13% year-to-date, while its 2026 trading range stood between ₹381 and ₹555.80.

The main risks include:

  • Execution risk in the new alcohol business.
  • Regulatory and licensing requirements.
  • Margin pressure from international acquisitions.
  • Higher investment before new products begin generating revenue.

VBL also trades at a premium valuation, which leaves less room for mistakes if the new business takes longer than expected to deliver results.

What Could Drive the Next Move in VBL Stock?

The next catalyst could be greater clarity on KIVA Spirits, including its products, investment plans, and launch timing. Investors will also watch international volumes, margin recovery, and the performance of new products. An AI stock analysis tool such as Meyka can provide another layer of analysis alongside company filings and broker research.

Varun Beverages Stock Forecast: What Meyka Says

Meyka’s VBL.NS page shows an AI Price Forecast of $457.63 for one month, $376.69 for three months, and $739.33 for one year, based on the data available on its platform. It also gives VBL an AI Score of B+.

Short Stock Details and Technical Analysis Summary

Meyka’s technical data has highlighted an RSI of 72.14, which indicates an overbought reading in the data captured by the platform. The model points to a mixed short-term setup, even as its longer-term forecast remains stronger.

What Meyka Says?

Meyka’s analysis suggests investors should watch both valuation and earnings growth rather than focus only on the new alcobev opportunity. Its platform also points to the stock’s forecast potential as a positive factor.

Supporting Analyst Insights: Is VBL Stock Still Attractive?

Morgan Stanley’s ₹557 target remains positive. Other brokerages also have higher targets. CLSA has a ₹629 target, Jefferies has ₹615, Citi has ₹580, and UBS has ₹585. The range shows that analysts remain broadly positive, although their expectations for the pace of future growth differ.

Jefferies said the recent correction appeared excessive and pointed to improving July demand. Citi also remained positive despite cutting its target after the Q2 margin miss.

Conclusion

Varun Beverages stock now has another growth factor to consider. Its core business continues to deliver strong volume and profit growth, while KIVA Spirits gives the company an entry into RTD and alcobev. Morgan Stanley’s ₹557 target remains positive, but execution will determine the outcome. Investors should watch regulatory approvals, product launches, margins, and international growth as the strategy develops.

Disclaimer:

The content shared by Meyka AI PTY LTD is for research and informational purposes only. Meyka is not a financial advisory service, and the information provided should not be treated as investment or trading advice.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)